Literature DB >> 1590585

Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatography/mass spectrometry.

D L Ashley1, M A Bonin, F L Cardinali, J M McCraw, J S Holler, L L Needham, D G Patterson.   

Abstract

Volatile organic compounds (VOCs) are a major public health concern, because of their ubiquitous nature and the possible health effects associated with exposure to them. An analytical method has been developed that enabled the determination of parts per trillion levels of 32 VOCs in 10 mL of blood. Special efforts toward reducing blank levels and improving measurement sensitivity have resulted in an analytical method that shows excellent reproducibility and recovery even at these ultratrace levels. Results on normal human blood indicate that quantifiable levels of eleven VOCs can be found in virtually all whole blood samples. In a fraction of the samples, six other VOCs can also be determined at levels above detection limits. This method shows promise as a technique for estimating the normal baseline level of VOCs in human blood and may have future applications in cases of exposure.

Entities:  

Mesh:

Year:  1992        PMID: 1590585     DOI: 10.1021/ac00033a011

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  27 in total

1.  Importance of enhanced mass resolution in removing interferences when measuring volatile organic compounds in human blood by using purge-and-trap gas chromatography/mass spectrometry.

Authors:  M A Bonin; D L Ashley; F L Cardinali; J M McGraw; D G Patterson
Journal:  J Am Soc Mass Spectrom       Date:  1992-11       Impact factor: 3.109

2.  Using the blood concentration of 2,5-dimethylfuran as a marker for smoking.

Authors:  D L Ashley; M A Bonin; B Hamar; M McGeehin
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

Review 3.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

4.  Volatile organic compounds in the blood of persons in Kuwait during the oil fires.

Authors:  R A Etzel; D L Ashley
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

5.  Surface plasmon resonance imaging of gold-small molecule interactions is influenced by refractive index and chemical structures.

Authors:  Zainab H Al Mubarak; Rajagopal Ramesh; Lin Liu; Sadagopan Krishnan
Journal:  J Colloid Interface Sci       Date:  2015-08-25       Impact factor: 8.128

6.  Contemporary Issues in Exposure Assessment Using Biomonitoring.

Authors:  Antonia M Calafat
Journal:  Curr Epidemiol Rep       Date:  2016-06

7.  Human exposure to volatile organic compounds: a comparison of organic vapor monitoring badge levels with blood levels.

Authors:  D M Mannino; J Schreiber; K Aldous; D Ashley; R Moolenaar; D Almaguer
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

8.  Cytogenetic analysis of an exposed-referent study: perchloroethylene-exposed dry cleaners compared to unexposed laundry workers.

Authors:  James D Tucker; Karen J Sorensen; Avima M Ruder; Lauralynn Taylor McKernan; Christy L Forrester; Mary Ann Butler
Journal:  Environ Health       Date:  2011-03-10       Impact factor: 5.984

9.  Influence of tap water quality and household water use activities on indoor air and internal dose levels of trihalomethanes.

Authors:  John R Nuckols; David L Ashley; Christopher Lyu; Sydney M Gordon; Alison F Hinckley; Philip Singer
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

10.  What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data?

Authors:  Antonia M Calafat; Larry L Needham
Journal:  Environ Health Perspect       Date:  2009-06-24       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.